Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision | ||
content:alpha-feto_protein_serum [2020/02/16 20:53] – icna | content:alpha-feto_protein_serum [2020/02/17 19:41] – [Alpha-Feto protein, serum] icna | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Alpha-Feto protein, serum ====== | ====== Alpha-Feto protein, serum ====== | ||
- | <alert type=" | + | {{page>:template:stub}} |
{{tag> | {{tag> | ||
==== Indications ==== | ==== Indications ==== | ||
Line 8: | Line 8: | ||
Increased serum AFP is a biomarker for [[Ataxia Telangiectasia]], | Increased serum AFP is a biomarker for [[Ataxia Telangiectasia]], | ||
- | |||
- | CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[(: | ||
- | * median 61 kIU/L (5th-95th centile: 2-889 kIU/L) in infants -69 to 31 days old | ||
- | * median 1.2 kIU/L (5th-95th centile: 0.1-12.5 kIU/L) in infants 32 to 110 days old | ||
* **Classic Ataxia Telangiectasia** | * **Classic Ataxia Telangiectasia** | ||
Line 36: | Line 32: | ||
* raised serum/csf lactate | * raised serum/csf lactate | ||
- | ==== References ==== | + | CSF AFP levels in normal infants also decline with gestational age in proportion to levels of AFP in serum[(: |
- | ~~REFNOTES~~ | + | * median 61 kIU/L (5th-95th centile: 2-889 kIU/L) in infants -69 to 31 days old |
+ | * median 1.2 kIU/L (5th-95th centile: 0.1-12.5 kIU/L) in infants 32 to 110 days old |